Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.

Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
复制标题

氯喹通过将肿瘤相关巨噬细胞重置为 M1 表型来调节抗肿瘤免疫反应

DOI:
10.1038/s41467-018-03225-9
复制
发表时间:
2018-02-28
影响因子:
16.6
通讯作者:
Huang B
Huang B
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Chen D;Xie J;Fiskesund R;Dong W;Liang X;Lv J;Jin X;Liu J;Mo S;Zhang T;Cheng F;Zhou Y;Zhang H;Tang K;Ma J;Liu Y;Huang B

文献摘要

参考文献

被引文献

相似文献

重置肿瘤相关巨噬细胞(TAMs)是改善免疫抑制性肿瘤微环境,提高先天性和适应性抗肿瘤免疫的一种有前途的策略。在这里,我们表明,氯喹(CQ),一种经过验证的抗疟疾药物,可以作为一种抗肿瘤免疫调节剂,开关TAM从M2到肿瘤杀伤M1表型。从机制上讲,CQ增加巨噬细胞溶酶体pH值,通过溶酶体Ca 2+通道粘磷脂-1(Mcoln 1)引起Ca 2+释放,从而诱导p38和NF-κB活化,从而使TAM极化为M1表型。同时,释放的Ca 2+激活转录因子EB(TFEB),其将TAM的代谢从氧化磷酸化重新编程为糖酵解。因此,CQ重置巨噬细胞通过减少髓源性抑制细胞和Treg细胞的免疫抑制性浸润来改善肿瘤免疫微环境,从而增强抗肿瘤T细胞免疫。这些数据阐明了CQ以前未被认识的抗肿瘤机制,表明了一种潜在的新的基于巨噬细胞的肿瘤免疫模式。
Resetting tumor-associated macrophages (TAMs) is a promising strategy to ameliorate the immunosuppressive tumor microenvironment and improve innate and adaptive antitumor immunity. Here we show that chloroquine (CQ), a proven anti-malarial drug, can function as an antitumor immune modulator that switches TAMs from M2 to tumor-killing M1 phenotype. Mechanistically, CQ increases macrophage lysosomal pH, causing Ca2+release via the lysosomal Ca2+channel mucolipin-1 (Mcoln1), which induces the activation of p38 and NF-κB, thus polarizing TAMs to M1 phenotype. In parallel, the released Ca2+activates transcription factor EB (TFEB), which reprograms the metabolism of TAMs from oxidative phosphorylation to glycolysis. As a result, CQ-reset macrophages ameliorate tumor immune microenvironment by decreasing immunosuppressive infiltration of myeloid-derived suppressor cells and Treg cells, thus enhancing antitumor T-cell immunity. These data illuminate a previously unrecognized antitumor mechanism of CQ, suggesting a potential new macrophage-based tumor immunotherapeutic modality.
DOI: 10.1016/j.celrep.2015.08.077
发表时间: 2015-10-13
期刊: Cell reports
影响因子: 8.8
作者:
Holmgaard RB;Zamarin D;Li Y;Gasmi B;Munn DH;Allison JP;Merghoub T;Wolchok JD
通讯作者: Wolchok JD
DOI: 10.1038/ni.2956
发表时间: 2014-09
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.1038/nature20554
发表时间: 2016-11-17
期刊: Nature
影响因子: 64.8
作者:
De Henau O;Rausch M;Winkler D;Campesato LF;Liu C;Cymerman DH;Budhu S;Ghosh A;Pink M;Tchaicha J;Douglas M;Tibbitts T;Sharma S;Proctor J;Kosmider N;White K;Stern H;Soglia J;Adams J;Palombella VJ;McGovern K;Kutok JL;Wolchok JD;Merghoub T
通讯作者: Merghoub T
DOI: 10.1016/j.ccell.2017.10.005
发表时间: 2017-11-13
期刊: Cancer cell
影响因子: 50.3
作者:
Kumar V;Donthireddy L;Marvel D;Condamine T;Wang F;Lavilla-Alonso S;Hashimoto A;Vonteddu P;Behera R;Goins MA;Mulligan C;Nam B;Hockstein N;Denstman F;Shakamuri S;Speicher DW;Weeraratna AT;Chao T;Vonderheide RH;Languino LR;Ordentlich P;Liu Q;Xu X;Lo A;Puré E;Zhang C;Loboda A;Sepulveda MA;Snyder LA;Gabrilovich DI
通讯作者: Gabrilovich DI
DOI: 10.1091/mbc.e14-05-0967
发表时间: 2014-11-01
影响因子: 3.3
作者:
Canton J;Khezri R;Glogauer M;Grinstein S
通讯作者: Grinstein S